Scientific Reports (Aug 2021)
Role of the IL33 and IL1RL1 pathway in the pathogenesis of Immunoglobulin A vasculitis
- Diana Prieto-Peña,
- Sara Remuzgo-Martínez,
- Fernanda Genre,
- Verónica Pulito-Cueto,
- Belén Atienza-Mateo,
- Javier Llorca,
- Belén Sevilla-Pérez,
- Norberto Ortego-Centeno,
- Ana Marquez,
- Leticia Lera-Gómez,
- María Teresa Leonardo,
- Ana Peñalba,
- Javier Narváez,
- Luis Martín-Penagos,
- Emilio Rodrigo,
- José A. Miranda-Filloy,
- Luis Caminal-Montero,
- Paz Collado,
- Javier Sánchez Pérez,
- Diego de Argila,
- Esteban Rubio,
- Manuel León Luque,
- Juan María Blanco-Madrigal,
- Eva Galíndez-Agirregoikoa,
- Oreste Gualillo,
- Javier Martín,
- Santos Castañeda,
- Ricardo Blanco,
- Miguel A. González-Gay,
- Raquel López-Mejías
Affiliations
- Diana Prieto-Peña
- Research Group On Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System, IDIVAL, Division of Rheumatology, Hospital Universitario Marqués de Valdecilla
- Sara Remuzgo-Martínez
- Research Group On Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System, IDIVAL, Division of Rheumatology, Hospital Universitario Marqués de Valdecilla
- Fernanda Genre
- Research Group On Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System, IDIVAL, Division of Rheumatology, Hospital Universitario Marqués de Valdecilla
- Verónica Pulito-Cueto
- Research Group On Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System, IDIVAL, Division of Rheumatology, Hospital Universitario Marqués de Valdecilla
- Belén Atienza-Mateo
- Research Group On Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System, IDIVAL, Division of Rheumatology, Hospital Universitario Marqués de Valdecilla
- Javier Llorca
- Epidemiology and Computational Biology Department, School of Medicine, Universidad de Cantabria, and CIBER Epidemiología y Salud Pública (CIBERESP)
- Belén Sevilla-Pérez
- Division of Paediatrics, Hospital Universitario San Cecilio
- Norberto Ortego-Centeno
- Department of Medicine, Universidad de Granada
- Ana Marquez
- Instituto de Parasitología y Biomedicina ‘López-Neyra’, CSIC, PTS Granada
- Leticia Lera-Gómez
- Research Group On Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System, IDIVAL, Division of Rheumatology, Hospital Universitario Marqués de Valdecilla
- María Teresa Leonardo
- Division of Paediatrics, Hospital Universitario Marqués de Valdecilla
- Ana Peñalba
- Division of Paediatrics, Hospital Universitario Marqués de Valdecilla
- Javier Narváez
- Division of Rheumatology, Hospital Universitario de Bellvitge
- Luis Martín-Penagos
- Division of Nephrology, Hospital Universitario Marqués de Valdecilla, IDIVAL-REDINREN
- Emilio Rodrigo
- Division of Nephrology, Hospital Universitario Marqués de Valdecilla, IDIVAL-REDINREN
- José A. Miranda-Filloy
- Division of Rheumatology, Hospital Universitario Lucus Augusti
- Luis Caminal-Montero
- Division of Rheumatology, Hospital Universitario Central de Asturias, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA)
- Paz Collado
- Division of Rheumatology, Hospital Universitario Severo Ochoa
- Javier Sánchez Pérez
- Department of Dermatology, Hospital Universitario de La Princesa
- Diego de Argila
- Department of Dermatology, Hospital Universitario de La Princesa
- Esteban Rubio
- Department of Rheumatology, Hospital Universitario Virgen del Rocío
- Manuel León Luque
- Department of Rheumatology, Hospital Universitario Virgen del Rocío
- Juan María Blanco-Madrigal
- Department of Rheumatology, Hospital Universitario de Basurto
- Eva Galíndez-Agirregoikoa
- Department of Rheumatology, Hospital Universitario de Basurto
- Oreste Gualillo
- SERGAS (Servizo Galego de Saude) and IDIS (Instituto de Investigación Sanitaria de Santiago), NEIRID Lab (Neuroendocrine Interactions in Rheumatology and Inflammatory Diseases), Research Laboratory 9, Hospital Clínico Universitario de Santiago
- Javier Martín
- Instituto de Parasitología y Biomedicina ‘López-Neyra’, CSIC, PTS Granada
- Santos Castañeda
- Department of Rheumatology, Hospital Universitario de La Princesa, IIS-Princesa
- Ricardo Blanco
- Research Group On Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System, IDIVAL, Division of Rheumatology, Hospital Universitario Marqués de Valdecilla
- Miguel A. González-Gay
- Research Group On Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System, IDIVAL, Division of Rheumatology, Hospital Universitario Marqués de Valdecilla
- Raquel López-Mejías
- Research Group On Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System, IDIVAL, Division of Rheumatology, Hospital Universitario Marqués de Valdecilla
- DOI
- https://doi.org/10.1038/s41598-021-95762-5
- Journal volume & issue
-
Vol. 11,
no. 1
pp. 1 – 8
Abstract
Abstract Cytokines signalling pathway genes are crucial factors of the genetic network underlying the pathogenesis of Immunoglobulin-A vasculitis (IgAV), an inflammatory vascular condition. An influence of the interleukin (IL)33- IL1 receptor like (IL1RL)1 signalling pathway on the increased risk of several immune-mediated diseases has been described. Accordingly, we assessed whether the IL33-IL1RL1 pathway represents a novel genetic risk factor for IgAV. Three tag polymorphisms within IL33 (rs3939286, rs7025417 and rs7044343) and three within IL1RL1 (rs2310173, rs13015714 and rs2058660), that also were previously associated with several inflammatory diseases, were genotyped in 380 Caucasian IgAV patients and 845 matched healthy controls. No genotypes or alleles differences were observed between IgAV patients and controls when IL33 and IL1RL1 variants were analysed independently. Likewise, no statistically significant differences were found in IL33 or IL1RL1 genotype and allele frequencies when IgAV patients were stratified according to the age at disease onset or to the presence/absence of gastrointestinal (GI) or renal manifestations. Similar results were disclosed when IL33 and IL1RL1 haplotypes were compared between IgAV patients and controls and between IgAV patients stratified according to the clinical characteristics mentioned above. Our results suggest that the IL33-IL1RL1 signalling pathway does not contribute to the genetic network underlying IgAV.